New Treatment Option for ADHD: Unique Pharmacokinetic Profile and Range of Dosing Options

The US Food and Drug Administration has approved Tris Pharma’s Dyanavel XR (amphetamine), extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years and older…Dyanavel XR is a central nervous system stimulant prescription medicine used for the treatment of ADHD in individuals aged 6 years and older.

Read More

Children with ADHD and Reward-Related Dysfunctions: The Impact of Oppositional and Callous-Unemotional Symptoms

According to recent research, about 50% of patients with attention-deficit/hyperactivity disorder (ADHD) also develop oppositional defiant and conduct disorder (ODD/CD).1 Additionally, callous-unemotional (CU) traits—including reduced guilt and remorse, callousness, low empathy, and deficient prosocial emotions—overlap with the dimensions of ADHD and ODD/CD symptoms.

Read More

From Day 1: ADHD and Comorbid Conditions

“It’s important that from day 1 we see the patient, we are looking for comorbidities,” said Napoleon B. Higgins, Jr, MD, at the 2021 NEI Congress in his talk “There’s More to It: ADHD and Comorbidities”…More than 50% of individuals with ADHD have comorbid disorders. Comorbid conditions include learning and language disabilities, mood disorders like…

Read More

Behavior similar to human ADHD seen in dogs

A study of about 11,000 dogs conducted at the University of Helsinki found that gender, age, Dog breeds and behavioral problems and certain environmental factors are associated with hyperactivity and impulsive behavior and inattention (ADHD).

Read More

A Quick Guide to Adult Attention-Deficit Disorder

KEY POINTS: Adults who have undiagnosed or untreated ADHD often struggle with anxiety and depression. What seem like other mental problems are often byproducts of the ADHD itself. The keys to managing ADHD are developing good organizational skills and considering medication.

Read More

Is ADHD a neurological disorder?

Historically, doctors used the term psychological to refer to conditions involving specific mental states, such as emotions, thoughts, and behaviors, which present through human interactions. Neurological was the term for medical conditions that have a more clear-cut origin in the brain. Finally, psychiatric conditions were those that originated in the brain but had no obviousTrusted…

Read More

National Emergency Declared for Children’s Mental Health

KEY POINTS: Escalation of mental health needs in children over the past decade has worsened under the COVID pandemic. Evidence-based services for children’s mental health are not sufficiently accessible. Three major organizations (AAP, AACAP, CHA) call for significantly increased investment in improving children’s mental health.

Read More

ADHD the Focus of International Conference Hosted by CHADD, ADDA, and ACO

More than 1,500 members of the global ADHD community will convene from November 4 through 6 for the 2021 Virtual International Conference on ADHD. This premier event, hosted by three leading nonprofit organizations─CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder), ADDA (Attention Deficit Disorder Association), and ACO (ADHD Coaches Organization)─delivers three days of ADHD-focused science, education,…

Read More